BioAlliance Pharma announces participation in the Midcap Event on September 20 and 21, 2010
9 Sep, 2010
BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the supportive care and treatment of cancer patients, today announced that it will participate in the Midcap Event, a forum dedicated to meetings between institutional investors and listed companies from the Euronext Zone. The Midcap Event will take place on Monday 20 and Tuesday 21 of September in Paris at the Palais Brongniart, 19 rue Notre-Dame des Victoires.
During these two days, Dominique Costantini, CEO, and Nicolas Fellmann, Chief Financial Officer will meet with institutional investors to present BioAlliance Pharma’s development strategy, as well as the significant advances that were recently achieved.